MedPath
FDA Approval

Nefazodone Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 16, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Nefazodone(100 mg in 1 1)

Products5

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nefazodone Hydrochloride

Product Details

NDC Product Code
0093-1024
Application Number
ANDA076037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 16, 2021
Code: 27X63J94GRClass: ACTIBQuantity: 100 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT

Nefazodone Hydrochloride

Product Details

NDC Product Code
0093-7178
Application Number
ANDA076037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 16, 2021
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: 27X63J94GRClass: ACTIBQuantity: 50 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT

Nefazodone Hydrochloride

Product Details

NDC Product Code
0093-7113
Application Number
ANDA076037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 16, 2021
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: 27X63J94GRClass: ACTIBQuantity: 150 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT

Nefazodone Hydrochloride

Product Details

NDC Product Code
0093-1026
Application Number
ANDA076037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 16, 2021
Code: 27X63J94GRClass: ACTIBQuantity: 250 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT

Nefazodone Hydrochloride

Product Details

NDC Product Code
0093-1025
Application Number
ANDA076037
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 16, 2021
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: 27X63J94GRClass: ACTIBQuantity: 200 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRTClass: IACT
© Copyright 2025. All Rights Reserved by MedPath